XBIT$1.96+2.08%

XBiotech Inc.

Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq

Mkt Cap:$59.76M

Float & O/S:

Inst Own:

DilutionScan read 7 of XBiotech Inc.'s SEC filings and found 1 convertible on file for XBIT. The latest dilution event on file is a convertible issuance on Jan 3, 2024. Analysis updated Oct 7, 2026.

Signal8 Summary

Raise routes on file: no active ATM, effective shelf, S-1 or equity line in the filings read · latest dilution event 1035 days ago

Overall Risk

Offering Ability

Overhead Supply

Historical

Cash Need

AI dilution summary

The dominant contractual driver and its mechanism, then each further driver ranked.

Latest dilution event

Jan 3, 2024 · Convertible

How we read filings

Every warrant, convertible, ATM and shelf, cited to the filing

A free account reads 3 tickers a day in full

Get Pro · every ticker

$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)

Share count and cash history

Shares outstanding, potential dilution and cash over time

Convertibles · 1

What is this?

Principal, conversion terms and dates with Pro

Convertible

Repaid

Principal

Conversion Price

Remaining principal

Shares on conversion
Interest rate
Maturity

Know who's about to sell into your XBIT trade

Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.